{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:00:56Z","timestamp":1780977656199,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.msard.2026.107187","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:41:04Z","timestamp":1775666464000},"page":"107187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The evolution of criteria for assessing disease activity and progression in multiple sclerosis (or the \u201csaga of acronyms\u201d)"],"prefix":"10.1016","volume":"111","author":[{"given":"Claude","family":"Mekies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107187_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104166","article-title":"Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization-results of a large-scale cross-sectional online survey (MS Perspectives","volume":"68","author":"Bayas","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2026.107187_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128386","article-title":"Magnetic resonance phase alterations in multiple sclerosis patients with short and long disease duration","volume":"10","author":"Bozin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107187_bib0007","article-title":"Silent progression in disease activity\u2013free relapsing multiple sclerosis","author":"Cree","year":"2019","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107187_bib0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaneurol.2020.4689","article-title":"Diagnosis of progressive multiple sclerosis from the imaging perspective: a review","volume":"78","author":"Filippi","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2026.107187_bib0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.msard.2017.07.011","article-title":"A brief history of NEDA author links open overlay","volume":"20","author":"Giovannoni","year":"2018","journal-title":"Mult. Scler. Relat. Disord. Vol."},{"key":"10.1016\/j.msard.2026.107187_bib0017","first-page":"1","article-title":"Smouldering multiple sclerosis: the \u00ab real MS \u00bb","volume":"15","author":"Giovannoni","year":"2022","journal-title":"Therap. Adv. Neurolog. Disorders Rev."},{"issue":"12","key":"10.1016\/j.msard.2026.107187_bib0013","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.msard.2026.107187_bib0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ana.25313","article-title":"Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial","volume":"84","author":"Jerry","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107187_bib0006","article-title":"Contribution of relapse-independent progression to disability in relapsing multiple sclerosis","author":"Kappos","year":"2018","journal-title":"JAMa Neurol."},{"issue":"963","key":"10.1016\/j.msard.2026.107187_bib0010","first-page":"73","article-title":"Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study","volume":"24","author":"Kappos","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107187_bib0004","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1212\/NXI.0000000000000358","article-title":"Comparative utility of disability progression measures in PPMS analysis of the PROMiSe data set neurology","volume":"4","author":"Koch","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.msard.2026.107187_bib0016","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","article-title":"Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: a systematic review","volume":"80","author":"M\u00fcller","year":"2023","journal-title":"JAMA Neurol."},{"issue":"2796","key":"10.1016\/j.msard.2026.107187_bib0008","first-page":"805","article-title":"Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study","volume":"145","author":"Portaccio","year":"2022","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.msard.2026.107187_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213977","article-title":"Toward a unified definition of progression independent of relapse activity in multiple sclerosis","volume":"105","author":"Portaccio","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107187_bib0002","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1352458517698052","article-title":"Disability progression markers over 6\u201312 years in interferon-beta-treated multiple sclerosis patients","volume":"24","author":"Rio","year":"2018","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2026.107187_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.27034","article-title":"Smouldering-associated worsening in multiple sclerosis: An international consensus statement on definition, biology, clinical implications, and future directions","volume":"96","author":"Scalfari","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107187_bib0003","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000002830","article-title":"Assessing response to interferon-beta in a multi- center dataset of patients with MS","volume":"87","author":"Sormani","year":"2016","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.msard.2026.107187_bib0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2023","journal-title":"JAMA Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:40:45Z","timestamp":1780976445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826002233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"alternative-id":["S2211034826002233"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107187","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution of criteria for assessing disease activity and progression in multiple sclerosis (or the \u201csaga of acronyms\u201d)","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107187"}}